幽门螺旋杆菌与高血压的联系及其机制的研究进展
Research Progress on the Relationship and Mechanism between Helicobacter pylori and Hypertension
DOI: 10.12677/acm.2025.1592699, PDF,   
作者: 何佳艳:赣南医科大学第一临床医学院,江西 赣州
关键词: 幽门螺旋杆菌高血压机制治疗Helicobacter pylori Hypertension Mechanism Treatment
摘要: 幽门螺旋杆菌是一种定植于胃中微需氧的革兰阴性杆菌,近年来的研究发现其可能与高血压的发生发展存在关联,本文现就幽门螺旋杆菌与高血压流行病学联系的最新证据,探讨了可能的发病机制,包括慢性炎症反应、肠道菌群失调以及代谢异常、胃肠黏膜的损伤与营养吸收障碍、高渗环境、维生素D代谢等方面,同时总结了相关临床研究进展和治疗意义,并对未来研究方向提出了展望,为深入理解幽门螺旋杆菌感染与高血压的关系提供了重要参考。
Abstract: Helicobacter pylori is a Gram-negative, microaerophilic bacterium that persistently colonizes the gastric mucosa. Accumulating evidence suggests its potential involvement in the pathogenesis and progression of hypertension. This review systematically evaluates current epidemiological evidence supporting the association between H. pylori infection and hypertension, while delineating potential mechanistic pathways, such as: Chronic low-grade inflammation, Gut microbiota dysbiosis and metabolic dysfunction, Gastrointestinal mucosal damage leading to impaired nutrient absorption, Induction of a hypertonic state, Disrupted vitamin D metabolism. Additionally, we synthesize recent advances in clinical research and highlight therapeutic implications. Finally, we propose future research directions to further elucidate the causal relationship between H. pylori infection and hypertension, offering valuable insights for both basic research and clinical practice.
文章引用:何佳艳. 幽门螺旋杆菌与高血压的联系及其机制的研究进展[J]. 临床医学进展, 2025, 15(9): 1900-1905. https://doi.org/10.12677/acm.2025.1592699

参考文献

[1] 李英霞, 李文明, 余秋华, 等. 《中国高血压临床实践指南》解读——护理实践要点及管理策略[J]. 基础医学与临床, 2025, 45(7): 974-980.
[2] Fang, Y., Xie, H. and Fan, C. (2022) Association of Hypertension with Helicobacter pylori: A Systematic Review and Meta-Analysis. PLOS ONE, 17, e0268686. [Google Scholar] [CrossRef] [PubMed]
[3] Yue, L., Zhang, R., Chen, S. and Duan, G. (2022) Relationship between Helicobacter pylori and Incident Hypertension as Well as Blood Pressure: A Systematic Review and Meta-Analysis. Digestive Diseases, 41, 124-137. [Google Scholar] [CrossRef] [PubMed]
[4] Hassan, A.A., Ahmed, B.E., Osman, O.E. and Adam, I. (2023) Association between Helicobacter pylori Seropositivity and Hypertension among Adults in Northern Sudan: A Community-Based Case-Control Study. Journal of International Medical Research, 51, 6. [Google Scholar] [CrossRef] [PubMed]
[5] Xiong, X., Chen, J., He, M., Wu, T. and Yang, H. (2020) Helicobacter pylori Infection and the Prevalence of Hypertension in Chinese Adults: The Dongfeng‐Tongji Cohort. The Journal of Clinical Hypertension, 22, 1389-1395. [Google Scholar] [CrossRef] [PubMed]
[6] 沈志明, 黄信鸿, 陈菁, 等. 赣南地区幽门螺旋杆菌同高血压相关性研究[J]. 实验与检验医学, 2022, 40(1): 112-115.
[7] 张喆. 幽门螺旋杆菌感染对血压及部分血清生化指标的影响[D]: [硕士学位论文]. 延安: 延安大学, 2020.
[8] Wan, Z., Hu, L., Hu, M., Lei, X., Huang, Y. and Lv, Y. (2017) Helicobacter pylori Infection and Prevalence of High Blood Pressure among Chinese Adults. Journal of Human Hypertension, 32, 158-164. [Google Scholar] [CrossRef] [PubMed]
[9] Migneco, A., Ojetti, V., Specchia, L., Franceschi, F., Candelli, M., Mettimano, M., et al. (2003) Eradication of Helicobacter pylori Infection Improves Blood Pressure Values in Patients Affected by Hypertension. Helicobacter, 8, 585-589. [Google Scholar] [CrossRef] [PubMed]
[10] Lu, C., Jia, H., Xu, A., et al. (2014) Helicobacter pylori Infection and Pepsinogen Levels Have Clinical Significance in Hypertension Patients. International Journal of Clinical and Experimental Medicine, 7, 5675-5680.
[11] Kopacova, M., et al. (2014) Blood Pressure and Stature in Helicobacter pylori Positive and Negative Persons. World Journal of Gastroenterology, 20, 5625-5631. [Google Scholar] [CrossRef] [PubMed]
[12] Gunji, T., Matsuhashi, N., Sato, H., Fujibayashi, K., Okumura, M., Sasabe, N., et al. (2008) Helicobacter pylori Infection Is Significantly Associated with Metabolic Syndrome in the Japanese Population. The American Journal of Gastroenterology, 103, 3005-3010. [Google Scholar] [CrossRef] [PubMed]
[13] Kalisperati, P., Spanou, E., Pateras, I.S., Korkolopoulou, P., Varvarigou, A., Karavokyros, I., et al. (2017) Inflammation, DNA Damage, Helicobacter pylori and Gastric Tumorigenesis. Frontiers in Genetics, 8, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
[14] Yamaoka, Y., Kita, M., Kodama, T., Sawai, N., Kashima, K. and Imanishi, J. (1997) Induction of Various Cytokines and Development of Severe Mucosal Inflammation by caga Gene Positive Helicobacter pylori Strains. Gut, 41, 442-451. [Google Scholar] [CrossRef] [PubMed]
[15] Kim, J., Montagnani, M., Koh, K.K. and Quon, M.J. (2006) Reciprocal Relationships between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms. Circulation, 113, 1888-1904. [Google Scholar] [CrossRef] [PubMed]
[16] Yusuf, S.W. and Mishra, R.M. (2002) Effect of Helicobacter pylori Infection on Fibrinogen Level in Elderly Patients with Ischaemic Heart Disease. Acta Cardiologica, 57, 317-322. [Google Scholar] [CrossRef] [PubMed]
[17] Xue, B., Zhang, Y. and Johnson, A.K. (2020) Interactions of the Brain Renin-Angiotensin-System (RAS) and Inflammation in the Sensitization of Hypertension. Frontiers in Neuroscience, 14, Article No. 650. [Google Scholar] [CrossRef] [PubMed]
[18] Franco, C., Sciatti, E., Favero, G., Bonomini, F., Vizzardi, E. and Rezzani, R. (2022) Essential Hypertension and Oxidative Stress: Novel Future Perspectives. International Journal of Molecular Sciences, 23, Article No. 14489. [Google Scholar] [CrossRef] [PubMed]
[19] Balendra, V., Amoroso, C., Galassi, B., Esposto, J., Bareggi, C., Luu, J., et al. (2023) High-Salt Diet Exacerbates H. pylori Infection and Increases Gastric Cancer Risks. Journal of Personalized Medicine, 13, Article No. 1325. [Google Scholar] [CrossRef] [PubMed]
[20] Palframan, S.L., Kwok, T. and Gabriel, K. (2012) Vacuolating Cytotoxin a (VacA), a Key Toxin for Helicobacter pylori Pathogenesis. Frontiers in Cellular and Infection Microbiology, 2, Article No. 92. [Google Scholar] [CrossRef] [PubMed]
[21] Aramouni, K., Assaf, R.K., Azar, M., Jabbour, K., Shaito, A., Sahebkar, A., et al. (2023) Infection with Helicobacter pylori May Predispose to Atherosclerosis: Role of Inflammation and Thickening of Intima-Media of Carotid Arteries. Frontiers in Pharmacology, 14, Article ID: 1285754. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, Y., Zhou, K., Zhang, Y., Li, C., Zhang, Y., Ren, X., et al. (2025) The Systemic Impact of Helicobacter pylori Infection on the Microbiome of Whole Digestive Tract Based on Mucosal, Gastric Juice, and Fecal Specimens. Helicobacter, 30, e70047. [Google Scholar] [CrossRef] [PubMed]
[23] Chen, C., Liou, J., Lee, Y., Hong, T., El-Omar, E.M. and Wu, M. (2021) The Interplay between Helicobacter pylori and Gastrointestinal Microbiota. Gut Microbes, 13, 1-22. [Google Scholar] [CrossRef] [PubMed]
[24] Nasrat, S.A.M. and Nasrat, A.M. (2015) An Alternative Approach for the Rising Challenge of Hypertensive Illness via Helicobacter pylori Eradication. Cardiology Research, 6, 221-225. [Google Scholar] [CrossRef] [PubMed]
[25] Huang, Y., Ding, Y., Xu, H., Shen, C., Chen, X. and Li, C. (2021) Effects of Sodium Butyrate Supplementation on Inflammation, Gut Microbiota, and Short‐Chain Fatty Acids in Helicobacter pylori‐Infected Mice. Helicobacter, 26, e12785. [Google Scholar] [CrossRef] [PubMed]
[26] Hu, T., Wu, Q., Yao, Q., Jiang, K., Yu, J. and Tang, Q. (2022) Short-Chain Fatty Acid Metabolism and Multiple Effects on Cardiovascular Diseases. Ageing Research Reviews, 81, Article ID: 101706. [Google Scholar] [CrossRef] [PubMed]
[27] He, Y., Liu, S., Kling, D.E., Leone, S., Lawlor, N.T., Huang, Y., et al. (2014) The Human Milk Oligosaccharide 2’-Fucosyllactose Modulates CD14 Expression in Human Enterocytes, Thereby Attenuating LPS-Induced Inflammation. Gut, 65, 33-46. [Google Scholar] [CrossRef] [PubMed]
[28] Battson, M.L., Lee, D.M., Weir, T.L. and Gentile, C.L. (2018) The Gut Microbiota as a Novel Regulator of Cardiovascular Function and Disease. The Journal of Nutritional Biochemistry, 56, 1-15. [Google Scholar] [CrossRef] [PubMed]
[29] Sipponen, P., Laxén, F., Huotari, K. and Härkönen, M. (2003) Prevalence of Low Vitamin B12 and High Homocysteine in Serum in an Elderly Male Population: Association with Atrophic Gastritis and Helicobacter pylori Infection. Scandinavian Journal of Gastroenterology, 38, 1209-1216. [Google Scholar] [CrossRef] [PubMed]
[30] Wu, D.F., Yin, R.X. and Deng, J.L. (2024) Homocysteine, Hyperhomocysteinemia, and H-Type Hypertension. European Journal of Preventive Cardiology, 31, 1092-1103. [Google Scholar] [CrossRef] [PubMed]
[31] Jiang, K., He, T., Ji, Y., Zhu, T. and Jiang, E. (2023) The Perspective of Hypertension and Salt Intake in Chinese Population. Frontiers in Public Health, 11, Article ID: 1125608. [Google Scholar] [CrossRef] [PubMed]
[32] Zaidi, S.F. (2016) Helicobacter pylori Associated Asian Enigma: Does Diet Deserve Distinction? World Journal of Gastrointestinal Oncology, 8, 341-350. [Google Scholar] [CrossRef] [PubMed]
[33] Fox, J.G., Dangler, C.A., Taylor, N.S., et al. (1999) High-Salt Diet Induces Gastric Epithelial Hyperplasia and Parietal Cell Loss, and Enhances Helicobacter pylori Colonization in C57BL/6 Mice. Cancer Research, 59, 4823-4828.
[34] Dahl, L. (2005) Possible Role of Salt Intake in the Development of Essential Hypertension. International Journal of Epidemiology, 34, 967-972. [Google Scholar] [CrossRef] [PubMed]
[35] Săsăran, M.O., Mărginean, C.O., Lupu, A. and Koller, A.M. (2023) Vitamin D and Its Association with H. pylori Prevalence and Eradication: A Comprehensive Review. Nutrients, 15, Article No. 3549. [Google Scholar] [CrossRef] [PubMed]
[36] Li, Y.C., Kong, J., Wei, M., Chen, Z., Liu, S.Q. and Cao, L. (2002) 1,25-Dihydroxyvitamin D3 Is a Negative Endocrine Regulator of the Renin-Angiotensin System. Journal of Clinical Investigation, 110, 229-238. [Google Scholar] [CrossRef] [PubMed]
[37] Latic, N. and Erben, R.G. (2020) Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension, Atherosclerosis, and Heart Failure. International Journal of Molecular Sciences, 21, Article No. 6483. [Google Scholar] [CrossRef] [PubMed]
[38] Kim, Y., Kim, Y.A., Lee, J.W., Kim, H.J., Kim, S., Kim, S.G., et al. (2020) Effect of Helicobacter pylori Treatment on Long-Term Mortality in Patients with Hypertension. Gut and Liver, 14, 47-56. [Google Scholar] [CrossRef] [PubMed]